MedPark Hospital Launches Genomics Laboratory and Genomic Medicine Services to Advance Targeted Cancer Therapy
Today, a one-size-fits-all approach to disease treatment is no longer the solution. Each patient responds differently to therapy at the genetic level, making treatment planning, particularly in cancer care, dependent on deeper, more relevant data.
Recognizing this need, MedPark Hospital has strengthened its genomic medicine capabilities and officially launched its Genomics Laboratory on Friday, 30 January 2026, at The Forum, MedPark Hospital. The initiative aims to support personalized care through precision medicine, enabling specific treatment strategies that align with each patient’s unique genetic profile.
Personalized Treatment Formulation Through Genomic Medicine
Dr. Pongpat Patanavanich, Managing Director of MedPark Hospital, stated, “Integrating genomic medicine into patient care enables physicians to gain a deeper understanding of each individual’s disease characteristics and supports more precise treatment planning, particularly for cancer and other complex conditions.”
Genetic information is a key component of precision medicine, allowing patient care to be more individualized while thoughtfully addressing long-term quality of life.
NGS Technology Expands Treatment Options through Precision Medicine
The Genomic Laboratory at MedPark Hospital utilizes NGS (Next-Generation Sequencing) technology, which enables simultaneous analysis of a large number of genes with high resolution and faster turnaround time. This advanced capability supports disease diagnosis, risk assessment, and treatment planning across a wide range of conditions.
Dr. Prasit Powthongkum, an internist specializing in medical genetics, pointed out, “Genomic medicine–based patient care requires careful clinical interpretation in conjunction with other health data, as well as close collaboration among multidisciplinary teams, to ensure that genetic test results are applied appropriately in patient care.”
Genomic Medicine Advances Targeted Cancer Therapy
Genomic medicine currently plays an ever more crucial role in supporting targeted therapy for patients with cancer. Analysis of driver genetic mutations in cancer cells is a key component in determining individualized treatment strategies.
Dr. Sudpreeda Chainitikun, an oncologist, explained that “Genetic testing using NGS technology enables a more comprehensive assessment of the biological characteristics of cancer and supports well-informed, individualized treatment decisions for each patient.”
Long-Term Health Management Through Genetic Risk Assessment for Hereditary Cancers
In addition to cancer treatment, MedPark Hospital also offers genetic testing to assess the risk of hereditary cancers. This service helps patients and their families plan appropriate long-term healthcare and preventive strategies.
Dr. Visitsak Suksa-ardphasu, Director of Laboratory and Radiology, commented, “Genetic testing supports preventive healthcare and is particularly beneficial for individuals with a family history of cancer and those who seek in-depth health screening to enable more appropriate long-term health planning.”
MedPark’s Genomic Laboratory Operates in Accordance with International Standards
The layout of the Genomic Laboratory at MedPark Hospital adheres to the principle of unidirectional workflow, with stringent environmental control and biosafety systems that meet international standards. The laboratory partners with Northwestern Medicine of Northwestern University to facilitate genomic testing, analysis, and interpretation, ensuring a reliable and internationally recognized standard.
Genomic medicine services and the Genomic Laboratory at MedPark Hospital further strengthen integrated patient care by utilizing genetic information to guide treatment decisions, ensuring more personalized care and better long-term quality of life for patients.
